Clinical Trial Update: Study of Stereotactic Radiotherapy for Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of stereotactic radiotherapy for breast cancer was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-09-19